Access issues:
Interview with Zachie Achmat
Achmat and the Treatment Action Campaign (TAC) have led the campaign on the streets, in a bid to force a change in government policy on the treatment of HIV/Aids.
WHO and HAI launch new pricing study
The World Health Organization (WHO) and Health Action International (HAI) announce the release today of Medicine Prices, a pricing manual outlining how to collect and analyse data for 30 widely-used medicines.
Email the Documentation Centre at WHO EDM to obtain a copy:
Data from the pilot studies will be available on HAI’s web site:
http://www.haiweb.org/medicineprices>www.haiweb.org/medicineprices
Indian drug-maker leads the charge for low-cost AIDS drugs
amfARs ‘Treat Asia’ – March 2003
http://www.amfar.org/cgi-bin/iowa/asia/news/index.html?record=3
Interview with Cipla CEO Yusuf Hamied
Predicting the public health impact of antiretrovirals: preventing HIV in developing countries
Researchers from UCLA and Harvard Medical School argue, that antiretrovirals should be considered as a prevention tool and not simply as a therapeutic tool.
Sally M. Blower and Paul Farmer. Full-text:
|
HIV Treatment Bulletin Vol 4 No 6 July 2003
|
|
|
 |
